血清sCD163、HMGB1联合对早发型子痫前期的诊断价值
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
目的探究血清可溶性单核巨噬细胞血红蛋白清道夫受体(sCD163)、高迁移率族蛋白B1(HMGB1)联合对早发型子痫前期(E-PE)的诊断价值。方法选取100例2022年5月至2024年3月在邯郸市中心医院收治的E-PE患者归为疾病组,另选择同期在邯郸市中心医院100例孕检正常的孕妇归为对照组。采用ELISA法检测血清sCD163、HMGB1表达水平;分析E-PE发生的影响因素;ROC曲线分析血清sCD163、HMGB1水平对E-PE的诊断价值。结果疾病组收缩压、舒张压、24 h尿蛋白定量显著高于对照组(P
Fields of Study & Subjects
Pregnancy and preeclampsia studies
Neurological Complications and Syndromes
Preterm Birth and Chorioamnionitis
Publication details
- Journal / source
- DOAJ (DOAJ: Directory of Open Access Journals)
- Publication date
- 1 March 2026
- Language
- ZH